About
Novus Diagnostics is a medical technology company based in Ireland that focuses on rapid point-of-care diagnostic solutions for infectious diseases, particularly sepsis. The company aims to empower clinicians by delivering critical diagnostic information quickly, which enhances early-stage treatment decisions. The company has developed a patented platform that integrates microfluidic electrochemical sensors with advanced diagnostic algorithms. This technology allows clinicians to obtain highly accurate results within 15 minutes at the bedside. Their flagship product, SepTec, is a rapid diagnostic device that detects bacterial and fungal infections in whole blood, confirming infections and classifying pathogens as gram-negative, gram-positive, or fungal. This rapid identification is essential for timely intervention in sepsis. Novus Diagnostics is committed to improving patient outcomes by providing reliable diagnostics that enable tailored therapies during the critical early stages of infection. The company has attracted significant investment to further develop and commercialize its rapid diagnostic technology, supporting healthcare professionals in making informed treatment decisions.
Technologies
Keywords
Company Information
- Employees20
- Founded2020
- Total Funding$12384252
Location
Collins Avenue Extension, Dublin, County Dublin, Ireland, D09 NR58
